The safety and efficacy of Laparoscopic Gastric Plication versus Laparoscopic sleeve gastrectomy in the treatment of morbid obesity
Phase 2
- Conditions
- Morbid obesity.Morbid obesity
- Registration Number
- IRCT2013123012294N5
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
morbid obesity ( BMI>40 kg/m2 or BMI>35kg/m2 with co-existing morbidities ); age 18 to 65; previous unsuccessful weight loss attempts Exclusion criteria: previous restrictive or malabsorptive procedure for obesity treatment; previous gastric surgery; history of anti-reflux surgery; pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent of excess weight loss. Timepoint: 24 months after surgery. Method of measurement: Weighing.;Operative time. Timepoint: During surgery. Method of measurement: With a clock.;Length of hospitalization. Timepoint: after discharging. Method of measurement: days of hospitalization.;Hypertension. Timepoint: 24 months follow-up. Method of measurement: clinical examination and non invasive blood pressure measurement.;Diabetes. Timepoint: 24-months follow-up. Method of measurement: FBS , HgA1c.;Hyperlipidemia. Timepoint: 24 months follow-up. Method of measurement: cholesterol level,triglyceride.
- Secondary Outcome Measures
Name Time Method